MEGA Stock Overview
Manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Mega Lifesciences Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿35.50 |
| 52 Week High | ฿44.25 |
| 52 Week Low | ฿35.00 |
| Beta | 0.39 |
| 11 Month Change | -10.69% |
| 3 Month Change | -7.19% |
| 1 Year Change | -12.88% |
| 33 Year Change | -33.95% |
| 5 Year Change | 16.39% |
| Change since IPO | 66.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| MEGA | TH Pharmaceuticals | TH Market | |
|---|---|---|---|
| 7D | -2.7% | -4.8% | 0.8% |
| 1Y | -12.9% | 8.0% | 3.1% |
Return vs Industry: MEGA underperformed the TH Pharmaceuticals industry which returned 8% over the past year.
Return vs Market: MEGA underperformed the TH Market which returned 3.1% over the past year.
Price Volatility
| MEGA volatility | |
|---|---|
| MEGA Average Weekly Movement | 3.7% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in TH Market | 10.3% |
| 10% least volatile stocks in TH Market | 2.4% |
Stable Share Price: MEGA has not had significant price volatility in the past 3 months compared to the TH market.
Volatility Over Time: MEGA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | n/a | Vivek Dhawan | www.megawecare.com |
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; eyes, heart, and skin; pain, sleeping, well-being, herbal, and cough and colds; and vitamins, probiotics, medical and sports nutrition, as well as kids’, men’s, and women’s care products.
Mega Lifesciences Public Company Limited Fundamentals Summary
| MEGA fundamental statistics | |
|---|---|
| Market cap | ฿30.95b |
| Earnings (TTM) | ฿1.85b |
| Revenue (TTM) | ฿15.88b |
16.8x
P/E Ratio1.9x
P/S RatioIs MEGA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEGA income statement (TTM) | |
|---|---|
| Revenue | ฿15.88b |
| Cost of Revenue | ฿8.14b |
| Gross Profit | ฿7.74b |
| Other Expenses | ฿5.90b |
| Earnings | ฿1.85b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.12 |
| Gross Margin | 48.74% |
| Net Profit Margin | 11.62% |
| Debt/Equity Ratio | 1.8% |
How did MEGA perform over the long term?
See historical performance and comparison